Where does Caroline Benn work?

Caroline Benn is Co-founder & CSO of LoQus23.

Where did Caroline Benn go to school?

Caroline Benn studied at King's College London (PhD, Molecular Neurogenetics); University of Sussex (1st class BSc (Hons), Neuroscience); Gravesend Grammar School for Girls (GCSE, A-level).

Caroline Benn

Founder

Co-founder & CSO at LoQus23

Greater Cambridge Area

FoundedLoQus23

Find your path to Caroline

327 people in our graph share verified history with Caroline — schools, employers, funds. One of them is your warm intro.

Itxaso del PalaciounlockedCaroline: together at UCL (2022–2026)

Caroline: together at UCL

×5Caroline: together at Pfizer

×5Caroline: together at University of Sussex

About

Caroline Benn is co-founder and Chief Scientific Officer of LoQus23 Therapeutics, where she works on small-molecule approaches targeting DNA damage repair mechanisms for repeat expansion diseases including Huntington's and Myotonic Dystrophy. She also serves as an Advisory Board Member at Alzheimer's Research UK. Her work focuses on drug discovery for neurodegenerative disease.

Co-founder & CSO at LoQus23

Intro paths

→

In turn, Caroline can intro founders to LoQus23's investors below.

LoQus23's investors · 4

Dementia Discovery FundLondon · since 2021 ForbionNaarden · since 2024 Novartis Venture FundBasel · $5M – $25M checks · since 2021 SV Health InvestorsBoston · $1M – $20M checks

Co-founders at LoQus23

David ReynoldsCo-founder & CEO

Experience

Alzheimer's Research UKAdvisory Board Membercurrent2022 — presentCambridge, United Kingdom
UCLVisiting Professorcurrent2022 — presentLondon, United Kingdom
LoQus23 Therapeutics LtdChief Scientific Officercurrent2020 — presentCambridge, England, United Kingdom
Dementia Discovery FundScientific Strategist2018 — 202077 Kingsway, Holborn, London
Astex Pharmaceuticals (US)Associate Director, CNS biology2016 — 2018Cambridge, United Kingdom
PfizerSenior Principal Scientist2013 — 2016Cambridge, United Kingdom
Pfizer Regenerative MedicinePrincipal Scientist2008 — 2013Cambridge UK
King's College LondonPostdoctoral research fellow2007 — 2008
Massacussetts General Hospital/Harvard Medical SchoolPostdoctoral Research Fellow2002 — 2007

Skills & more

Molecular Biology51Drug Discovery39Genetics14Stem Cells16Biomarkers16Sequencing7Regenerative Medicine3Neuroscience25In Vivo3Animal Models4Pharmacology4Biomarker Discovery3

+8 more

Cell CultureIn VitroCell BiologyImmunohistochemistryCellNeurodegenerationBiochemistryWestern Blotting

Languages French

From Caroline's professional profile.

Frequently asked questions

Who is Caroline Benn?: Caroline Benn is co-founder and Chief Scientific Officer of LoQus23 Therapeutics, where she works on small-molecule approaches targeting DNA damage repair mechanisms for repeat expansion diseases including Huntington's and Myotonic Dystrophy. She also serves as an Advisory Board Member at Alzheimer's Research UK. Her work focuses on drug discovery for neurodegenerative disease.
Where does Caroline Benn work?: Caroline Benn is Co-founder & CSO of LoQus23.
What companies did Caroline Benn found?: Caroline Benn founded LoQus23.
Where did Caroline Benn go to school?: Caroline Benn studied at King's College London (PhD, Molecular Neurogenetics); University of Sussex (1st class BSc (Hons), Neuroscience); Gravesend Grammar School for Girls (GCSE, A-level).

Founder mafias

King's College London mafia115

Also came through, then founded or led a company.

Harry StebbingsBachelor’s DegreeFounded Stride Ansuman SatpathyComputer ScienceFounded Santa Ana +4 Allen LawFounded Park Hotel Group +3 Jack TangBSCFounded Urban Massage +1 Andrew IveBSc Degree (HonsFounded Jellatech +1 Nicolas HourcardBsc (Hons)Founded QuestDB +1

+ 108 more

University of Sussex mafia26

Also came through, then founded or led a company.

Rashid MansoorDoctor of Philosophy (PhD Cand.)Founded HADEAN +2 Sumanta TalukdarPhDFounded WaveOptics +1 Ali Haghighi-MoodDoctor of Philosophy (PhD)Founded Sirona-Medical Technologies, Inc. +1 Amit PateMScFounded Snaptivityapp +1 Wilfrid ObengBachelor of Science (BSc)Founded Audiomob +1 Simon SegarsBEngFounded Arm

+ 19 more

Dementia Discovery mafia2

Also came through, then founded or led a company.

Jonathan BehrPartnerFounded Tilos Therapeutics +1

Same school

Also attended King's College London382

Harry StebbingsFounder & General Partner at 20VC Dominic JacquessonInvestor at Index Ventures John HortonInvestor at DN Capital Bob ThomasPartner at Oxx KatherineHealthcare Investment Lead at Hummingbird Ventures Özge Gizem YerlikayaGeneral Counsel at Idacapital

+ 376 more

Also attended University of Sussex118

Hamish GarnettAssociate at Manta Ray Ventures Molly CookeTeam Assistant at Northzone Jackson HeddyCFO at Northzone Georgia AbbottAssociate Director at Marlin Equity Partners Simon SegarsExecutive Advisor at Black Opal Ventures Yuki KanematsuOperations Manager at Sozo Ventures

+ 112 more

Shared employers

Also worked at Alzheimer's Research UK1

Damian Crowtherex-AstraZeneca at PICUS CAPITAL

Also worked at UCL161

Demis HassabisCo-founder & CEO of Google DeepMind Itxaso del PalacioGeneral Partner at Notion Capital Tess van StekelenburgPartner at Lux Capital Francesco MonacaInvestor at Giant Ventures Global Llp Dima KuzminManaging Partner at 4BIO Capital Therese LiechtensteinPartner at 4BIO Capital

+ 155 more

Also worked at Dementia Discovery Fund6

Damian Crowtherex-AstraZeneca at PICUS CAPITAL Christian JungPartner at Dementia Discovery Miles GersonPartner at Dementia Discovery Fund Jonathan BehrPartner at SV Health Investors Dirk LandgrafPrincipal at SV Health Investors Joanna WolakExecutive Officer, Director at EndLyz Therapeutics

Also worked at Astex Pharmaceuticals (US)4

Tim HainesExecutive Partner at Abingworth Qurrat Ul AinScience Journalist at Innovation UBC R G BoyleIndependent Representative of the Investment Advisory Panel at O2h Ventures Kartik KrishnanExecutive Officer, Director at Onconano